EXOSENS 53.150 € (-3,63 %) FDJ UNITED 21.530 € (-1,73 %) CRCAM NORD CCI 28.050 € (-1,92 %) PLANISWARE 17.820 € (-0,34 %) TONNER DRONES 0.025 € (-4,55 %) SAFRAN 342.300 € (+1,15 %) 
PROSUS 38.510 € (+0,23 %) ASML HOLDING 1 620.600 € (+4,30 %) CRCAM ATL.VEND.CCI 156.000 € (-1,02 %) 
THEON INTERNAT 31.460 € (-1,26 %) ACCOR 51.820 € (+3,56 %) 
MOTA ENGIL 4.784 € (+2,00 %) TOTALENERGIES 68.810 € (-1,01 %) SAINT GOBAIN 81.720 € (+2,35 %) ORANGE 16.985 € (+0,56 %) 
HAL TRUST 163.200 € (+0,25 %) BE SEMICONDUCTOR 296.700 € (+1,30 %) STELLANTIS NV 5.235 € (+1,04 %) SBM OFFSHORE 31.500 € (-2,05 %) STMICROELECTRONICS 65.850 € (+3,93 %) 
X-FAB 8.815 € (+0,06 %) JACQUET METALS 21.700 € (+0,23 %) GENFIT 9.450 € (-9,66 %) CSG 12.424 € (-2,82 %) AIRBUS 195.360 € (+0,13 %) ALSTOM 15.605 € (-1,89 %) ESSILORLUXOTTICA 165.750 € (-1,69 %) DASSAULT AVIATION 285.800 € (-3,12 %) CREDIT AGRICOLE 17.655 € (+0,66 %) EXOR NV 65.650 € (+0,69 %) ADYEN 825.300 € (-2,22 %) UMG 18.430 € (+0,44 %) 2CRSI 24.700 € (-7,14 %) EURAZEO 40.360 € (-1,18 %) ARKEMA 57.650 € (+0,17 %) HEINEKEN 74.560 € (0,00 %) KPN KON 4.419 € (-0,62 %) SANOFI 73.090 € (-0,63 %) TRIGANO 139.600 € (+4,49 %) FUGRO 9.940 € (-2,45 %) RANDSTAD NV 26.180 € (+0,46 %) SOCIETE GENERALE 77.240 € (+1,60 %) IMCD 82.420 € (+0,59 %) AIR LIQUIDE 170.180 € (+0,25 %) EMEIS 14.090 € (+0,93 %) EDENRED 22.400 € (+0,36 %) BASIC-FIT 32.260 € (+0,88 %) CAPGEMINI 88.860 € (-0,16 %) AXA 43.060 € (+0,61 %) PUBLICIS GROUPE SA 86.900 € (-1,34 %) LVMH 496.850 € (+0,78 %) STIF 57.450 € (-1,12 %) ARTMARKET COM 2.020 € (-0,49 %) 
UNILEVER 53.420 € (+1,27 %) SCHNEIDER ELECTRIC 282.350 € (+0,66 %) EUROFINS SCIENT. 67.400 € (+0,57 %) PHARMING GROUP 1.147 € (-0,22 %) SODEXO 51.300 € (+0,10 %) WAVESTONE 38.900 € (-2,51 %) DASSAULT SYSTEMES 17.545 € (+0,89 %) |
02/02/2023 13:00
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023CAMBRIDGE, MA / ACCESSWIRE / February 2, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 23, 2023 to report its fourth quarter and full year 2022 financial results, and provide a corporate update. A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call. About Moderna In 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic. Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past eight years. To learn more, visit www.modernatx.com. Investors: SOURCE: Moderna, Inc. View source version on accesswire.com: https://www.accesswire.com/737825/Moderna-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-Thursday-February-23-2023 Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière